Attendo AB (publ) (ATT.ST)
SEK 51.8
(1.77%)
SEK 51.8
(1.77%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.27 Billion SEK | 109.9% |
| 2022 | 616 Million SEK | -18.41% |
| 2021 | 755 Million SEK | 441.63% |
| 2020 | -221 Million SEK | -132.89% |
| 2019 | 672 Million SEK | -5.49% |
| 2018 | 711 Million SEK | -25.39% |
| 2017 | 953 Million SEK | 4.61% |
| 2016 | 911 Million SEK | 2.71% |
| 2015 | 887 Million SEK | 9.91% |
| 2014 | 807 Million SEK | 9.35% |
| 2013 | 738 Million SEK | 25.08% |
| 2012 | 590 Million SEK | 5.73% |
| 2011 | 558 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 261 Million SEK | -3.69% |
| 2024 Q3 | 510 Million SEK | 95.4% |
| 2024 Q1 | 271 Million SEK | 2.26% |
| 2023 Q2 | 268 Million SEK | 18.58% |
| 2023 Q1 | 226 Million SEK | 83.74% |
| 2023 Q3 | 519 Million SEK | 93.66% |
| 2023 FY | 1.29 Billion SEK | 109.9% |
| 2023 Q4 | 265 Million SEK | -48.94% |
| 2022 FY | 616 Million SEK | -18.41% |
| 2022 Q4 | 123 Million SEK | -58.59% |
| 2022 Q3 | 297 Million SEK | 226.37% |
| 2022 Q2 | 91 Million SEK | -28.35% |
| 2022 Q1 | 127 Million SEK | -21.6% |
| 2021 Q1 | 154 Million SEK | -8.33% |
| 2021 Q2 | 136 Million SEK | -11.69% |
| 2021 Q3 | 306 Million SEK | 125.0% |
| 2021 Q4 | 162 Million SEK | -47.06% |
| 2021 FY | 755 Million SEK | 441.63% |
| 2020 Q3 | 249 Million SEK | 129.33% |
| 2020 Q4 | 168 Million SEK | -32.53% |
| 2020 FY | -221 Million SEK | -132.89% |
| 2020 Q1 | 150 Million SEK | 44.23% |
| 2020 Q2 | -849 Million SEK | -666.0% |
| 2019 Q1 | 222 Million SEK | 8.82% |
| 2019 Q2 | 86 Million SEK | -61.26% |
| 2019 Q3 | 260 Million SEK | 202.33% |
| 2019 FY | 672 Million SEK | -5.49% |
| 2019 Q4 | 104 Million SEK | -60.0% |
| 2018 FY | 711 Million SEK | -25.39% |
| 2018 Q4 | 204 Million SEK | -21.54% |
| 2018 Q3 | 260 Million SEK | 182.61% |
| 2018 Q2 | 92 Million SEK | -54.23% |
| 2018 Q1 | 201 Million SEK | -1.95% |
| 2017 Q2 | 195 Million SEK | -21.37% |
| 2017 FY | 953 Million SEK | 4.61% |
| 2017 Q3 | 305 Million SEK | 56.41% |
| 2017 Q4 | 205 Million SEK | -32.79% |
| 2017 Q1 | 248 Million SEK | 18.1% |
| 2016 Q1 | 184 Million SEK | -8.46% |
| 2016 FY | 911 Million SEK | 2.71% |
| 2016 Q3 | 310 Million SEK | 49.76% |
| 2016 Q2 | 207 Million SEK | 12.5% |
| 2016 Q4 | 210 Million SEK | -32.26% |
| 2015 FY | 887 Million SEK | 9.91% |
| 2015 Q4 | 201 Million SEK | -39.64% |
| 2015 Q1 | 178 Million SEK | 27.14% |
| 2015 Q2 | 175 Million SEK | -1.69% |
| 2015 Q3 | 333 Million SEK | 90.29% |
| 2014 Q3 | 297 Million SEK | 0.0% |
| 2014 FY | 807 Million SEK | 9.35% |
| 2014 Q4 | 140 Million SEK | -52.86% |
| 2013 FY | 738 Million SEK | 25.08% |
| 2012 FY | 590 Million SEK | 5.73% |
| 2011 FY | 558 Million SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Ambea AB (publ) | 981 Million SEK | -29.867% |
| Humana AB (publ) | 378 Million SEK | -237.037% |
| ProstaLund AB (publ) | -16.85 Million SEK | 7660.382% |